Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kbp Biosciences

Kbp Biosciences?uq=3Oe4kK1Z
2007 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$76M LATEST DEAL AMOUNT
10 INVESTORS
Description

Developer of therapies in areas of unmet medical need in Cardiovascular, Infectious Disease, Respiratory, Inflammatory and Autoimmune diseases. The company is dedicated to the research, development and commercialization of innovative medicines in areas of unmet medical need. It is based on cutting-edge new drug development ideas and its own medicinal chemistry and CMC strengths, together with internal/external clinical development and regulatory expertise, the company devotes its resources towards identifying and progressing innovative NCEs with known mechanisms of action in validated targets for the treatment of patients with unmet medical needs in cardio-renal, infectious disease, respiratory, inflammatory and autoimmune diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 116 Village Boulevard
  • Suite 210
  • Princeton, NJ 08540
  • United States

+1 (609) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kbp Biosciences’s full profile, request a free trial.

Kbp Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 05-Jan-2018 $76M 0000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Kbp Biosciences Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Advantech Capital Partners Growth/Expansion Minority 000 0000 000000 0
Bay City Capital Venture Capital Minority 000 0000 000000 0
CASH Capital Venture Capital Minority 000 0000 000000 0
Cowin Capital Venture Capital Minority 000 0000 000000 0
Efung Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Kbp Biosciences Executive Team (6)

Name Title Board
Seat
Contact
Info
Fred Yang Ph.D Chief Development Officer
Vince Benn Ph.D Vice President, Regulatory & Medical Affairs
Robert Segal MD Deputy Chief Medical Officer

3 Former Executives

You’re viewing 3 of 6 executives. Get the full list »

Kbp Biosciences Board Members (4)

Name Representing Role Since Contact
Info
Benjamin Qiu Self Board Member 000 0000
Bing Wang Ph.D Self Board Member 000 0000
Huang Zhenhua Ph.D Kbp Biosciences Chairman & Founder 000 0000

1 Former Board Member

You’re viewing 3 of 4 board members. Get the full list »